发明名称 Amelioration of the development of cataracts and other ophthalmic diseases
摘要 Ophthalmically acceptable compositions used in arresting the development of cataracts or macular degeneration comprising a pharmaceutically acceptable carrier or diluent and a compound having the formula: where R1 and R2 are, independently, H or C1 to C3 alkyl; R3 and R4 are, independently C1 to C3 alkyl; and where R1 and R2, taken together, or R3 and R4, taken together, or both may be cycloalkyl; R5 is H, OH, or C1 to C6 alkyl; R6 is or C1 to C6 alkyl, alkenyl, alkynyl, or substituted alkyl or alkenyl; R7 is C1 to C6 alkyl, alkenyl, alkynyl, or substituted alkyl or alkenyl or where R6 and R7, or R5, R6 and R7, taken together, form a carbocycle or heterocycle having from 3 to 7 atoms in the ring.
申请公布号 US2004002461(A1) 申请公布日期 2004.01.01
申请号 US20030440583 申请日期 2003.05.19
申请人 MATIER WILLIAM L.;PATIL GHANSHYAM 发明人 MATIER WILLIAM L.;PATIL GHANSHYAM
分类号 A61K9/00;A61K9/02;A61K9/06;A61K9/08;A61K9/12;A61K9/20;A61K31/198;A61K31/445;A61K31/4525;A61K38/06;A61K47/20;A61P27/02;A61P27/12;C07D211/94;C07D401/12;C07D405/12;(IPC1-7):A61K38/05 主分类号 A61K9/00
代理机构 代理人
主权项
地址